Core Viewpoint - Jin Cheng Pharmaceutical announced a semi-annual distribution plan for 2025, proposing a cash dividend of 1 yuan per 10 shares (including tax), totaling approximately 37.93 million yuan, which represents 87.44% of the company's net profit [2]. Financial Performance - The company reported a revenue of 1.36 billion yuan for the first half of 2025, a year-on-year decrease of 22.65% - The net profit for the same period was 43.38 million yuan, down 66.78% year-on-year, with basic earnings per share of 0.11 yuan [2]. Dividend History - This marks the 17th cumulative cash distribution since the company's listing - The latest distribution plan is consistent with previous distributions, with varying amounts and dividend yields over the years [2]. Industry Comparison - In the pharmaceutical and biotechnology sector, 17 companies announced their semi-annual distribution plans for 2025 - WuXi AppTec led the sector with a cash distribution of 1 billion yuan, followed by China Resources Sanjiu and Baiyunshan with distributions of 751.31 million yuan and 650.32 million yuan, respectively [4].
金城医药2025半年度拟派3793.32万元红包